Namita Khanna, MD, MSPH
-
RoleGynecologic Oncology
-
Specialty
-
Research Program
-
Practicing Since2010
Background
Namita Khanna, MD, MSPH, is a gynecologic oncologist who sees patients at Emory Clinic. She specializes in gynecologic oncology, treating ovarian, uterine, vaginal, vulvar and cervical cancers, as well as other gynecologic malignancies.
Dr. Khanna believes it’s vital that women have an opportunity to receive care from other women in specialties once dominated by males. She says a more diverse physician population makes it easier to meet the needs of diverse patient populations.
Dr. Khanna stresses the importance and value of screening tests, such as Pap smears and HPV tests, to all women. They are simple procedures that can find cancer early when it is most treatable. In some cases, the tests may even help prevent cancer from developing. If you are diagnosed with cancer, Dr. Khanna is proud to offer the highest level of cancer care through the Winship Cancer Institute of Emory University. The Center is one of just 72 National Cancer Institute-designated Comprehensive Cancer Centers in the U.S. It offers compassionate, coordinated care to women with all types of gynecologic cancer, including the latest clinical trials.
Titles & Roles
-
Associate Professor, Department of Gynecology and ObstetricsEmory University School of Medicine
-
Director, Pelvic Surgery Fellowship, Department of Gynecology and ObstetricsEmory University School of Medicine
Education & Training
Education
- Fellowship, Gynecologic Oncology, 2010Jackson Memorial Hospital
- Residency, Ob/Gyn, 2006Jackson Memorial Hospital
- Internship, Ob/Gyn, 2003Jackson Memorial Hospital
- Medical Education, MBBS, 2000University of Calcutta-IND
Board Certifications
- Gynecologic OncologyAmerican Board of Obstetrics and Gynecology, 2012Obstetrics and GynecologyAmerican Board of Obstetrics and Gynecology, 2010
Research
-
- PhaseII/III
-
ConditionsEndometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Uterine Corpus Carcinosarcoma
- LocationEmory University Hospital Midtown, Emory Saint Joseph's Hospital, Grady Health System, Winship Cancer Institute
-
Publications
Title/Journal Authors Publication Date Comorbid conditions and survival among Black women with ovarian cancer.
Cancer
AR Richards, CE Johnson, NR Montalvo, AJ Alberg, EV Bandera, M Bondy, LJ Collin, ML Cote, TA Hastert, K Haller, N Khanna, JR Marks, ES Peters, B Qin, J Staples, PD Terry, A Lawson, JM Schildkraut, LC Peres 01/01/2025 Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ZA Barandouzi, T Eng, J Shelton, N Khanna, I Scott, R Meador, DW Bruner 10/11/2023 Oncology nursing forum
ZA Barandouzi, J Bai, TY Eng, P Patel, J Shelton, N Khanna, I Scott, J Remick, R Meador, D Watkins Bruner 02/17/2023 Gynecologic oncology reports
NS McCall, TY Eng, JW Shelton, S Hanasoge, PR Patel, AB Patel, AA McCook-Veal, JM Switchenko, TE Cole, N Khanna, CH Han, AN Gordon, KD Starbuck, JS Remick 12/01/2022 Journal of minimally invasive gynecology
AY Kohut, T Kuhn, LB Conrad, KJ Chua, M Abuelafiya, AN Gordon, L Flowers, T Orfanelli, S Blank, N Khanna 07/01/2022 Low-Dose Naltrexone in Endometrial Intraepithelial Neoplasia.
Pain medicine (Malden, Mass.)
AM McKenzie-Brown, N Khanna, V Singh 04/08/2022 ACR Appropriateness Criteria® Staging and Follow-up of Primary Vaginal Cancer.
Journal of the American College of Radiology : JACR
A Kilcoyne, RV Gottumukkala, SK Kang, EA Akin, C Hauck, NM Hindman, C Huang, N Khanna, R Paspulati, GM Rauch, T Said, AB Shinagare, EB Stein, AM Venkatesan, KE Maturen 11/01/2021 International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
KZ Hanley, IR Horowitz, A Gordon, J Meisel, N Khanna 09/01/2021 ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer.
Journal of the American College of Radiology : JACR
Y Lakhman, HA Vargas, C Reinhold, EA Akin, PR Bhosale, C Huang, SK Kang, N Khanna, A Kilcoyne, R Nicola, R Paspulati, GM Rauch, AB Shinagare, W Small, P Glanc 05/01/2021 Cancer nursing
J Bai, SM Belcher, R Meador, G Daniel, J Shelton, P Patel, M Dolan, J Arluck, N Khanna, I Horowitz, T Liu, D Watkins Bruner 03/01/2021 Frontiers in cellular and infection microbiology
D Tsementzi, R Meador, T Eng, P Patel, J Shelton, J Arluck, I Scott, M Dolan, N Khanna, KT Konstantinidis, DW Bruner 01/01/2021 Journal of lower genital tract disease
T Kuhn, C Finneran, A Kohut, E Wang, G Birdsong, U Krishnamurti, M Mosunjac, T Tadros, G Oprea, V Avadhani, S Boguslawski, S Karlow, P Schnatz, N Khanna, L Flowers 10/01/2020 Cancer medicine
D Tsementzi, A Pena-Gonzalez, J Bai, YJ Hu, P Patel, J Shelton, M Dolan, J Arluck, N Khanna, L Conrad, I Scott, TY Eng, KT Konstantinidis, DW Bruner 06/01/2020 Primary colonic extrauterine endometrial stromal sarcoma: A case and review of the literature.
Gynecologic oncology reports
K Kundu, T Kuhn, A Kohut, C Staley, K Hanley, N Khanna 05/01/2020 Applied immunohistochemistry & molecular morphology : AIMM
LA Rubinsak, C Cohen, N Khanna, IR Horowitz, KZ Hanley 09/01/2018 International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
VM Alexander, AN Gordon, DH Howard, N Khanna 09/01/2017 Gynecologic oncology
R Salani, N Khanna, M Frimer, RE Bristow, LM Chen 07/01/2017 Gynecologic oncology reports
VM Alexander, J Meisel, S O'Brien, N Khanna 02/01/2017 Margins for cervical and vulvar cancer.
Journal of surgical oncology
N Khanna, LA Rauh, MP Lachiewicz, IR Horowitz 03/01/2016 Gynecologic oncology reports
CH Han, X Li, N Khanna 01/01/2016 Abdominal imaging
T Ciszak, PK Mittal, P Sullivan, K Cardona, KZ Hanley, N Khanna, CC Moreno 10/01/2015 Controversies in the management of advanced ovarian cancer.
Oncology (Williston Park, N.Y.)
N Khanna, IR Horowitz 09/01/2011 Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
4.9 Provider showed concern 4.8 Provider explained things clearly 4.8 Provider discussed treatment options 4.8 Provider included you in decisions 4.8 Likelihood of recommending this provider